TY - JOUR
T1 - Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation
T2 - A single-institute experience in Taiwan
AU - Cheng, Chao Neng
AU - Li, Sin Syue
AU - Yeh, Yun Hsuan
AU - Shen, Ching Fen
AU - Chen, Jiann Shiuh
N1 - Publisher Copyright:
© 2022
PY - 2022/4
Y1 - 2022/4
N2 - From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.
AB - From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.
UR - http://www.scopus.com/inward/record.url?scp=85125439476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125439476&partnerID=8YFLogxK
U2 - 10.1016/j.jmii.2022.01.002
DO - 10.1016/j.jmii.2022.01.002
M3 - Article
C2 - 35241378
AN - SCOPUS:85125439476
SN - 1684-1182
VL - 55
SP - 323
EP - 327
JO - Journal of Microbiology, Immunology and Infection
JF - Journal of Microbiology, Immunology and Infection
IS - 2
ER -